Active, Not Recruiting
A Study on the Safety and Immune Response to an mRNA-based RSV Investigational Vaccine in Healthy Adults Aged 18-45 Years
NCT06573281
- Conditions
- Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
- Locations
-
- GSK Investigational Site Rolling Hills Estates, California, United States
- GSK Investigational Site Atlanta, Georgia, United States
- GSK Investigational Site Lenexa, Kansas, United States
- GSK Investigational Site Omaha, Nebraska, United States